TYNDALL JOSEPH A.

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 19% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
TYNDALL JOSEPH A.'s trades of AxoGen, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
154.47
Quantity 85,803 -46.9%
Value US$2,937,266
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
39.68
Quantity 22,974
Value US$4,191,030
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
455.43
Quantity 4,209 -4.4%
Value US$999,973
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
30.98
Quantity 14,248 -56.7%
Value US$441,360
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
30.98
Quantity 25,108
Value US$777,771
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
10.72
Quantity 26,931 -100.0%
Value US$288,700
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
10.72
Quantity 26,931
Value US$288,814
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
11.20
Quantity 7,212 -32.0%
Value US$80,774
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
11.20
Quantity 12,850 -36.3%
Value US$143,920
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
11.15
Quantity 32,339
Value US$360,580
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
11.63
Quantity 2,525 -10.1%
Value US$29,366
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-02
US AxoGen, Inc. (AXGN)
PlS Planned sale
85,803 -46.9%
154.47
US$2,937,266 		85,803 -46.9% 154.47 US$2,937,266
2026-09-02 2026-09-02
US AxoGen, Inc. (AXGN)
PrS Proposed sale
22,974
39.68
US$4,191,030 		22,974 39.68 US$4,191,030
2025-12-10 2025-12-09
US AxoGen, Inc. (AXGN)
S Sale
4,209 -4.4%
455.43
US$999,973 		4,209 -4.4% 455.43 US$999,973
2025-12-10 2025-12-09
US AxoGen, Inc. (AXGN)
S Sale
14,248 -56.7%
30.98
US$441,360 		14,248 -56.7% 30.98 US$441,360
2025-12-09 2025-12-09
US AxoGen, Inc. (AXGN)
PrS Proposed sale
25,108
30.98
US$777,771 		25,108 30.98 US$777,771
2025-06-11 2025-06-10
US AxoGen, Inc. (AXGN)
S Sale
26,931 -100.0%
10.72
US$288,700 		26,931 -100.0% 10.72 US$288,700
2025-06-10 2025-06-10
US AxoGen, Inc. (AXGN)
PrS Proposed sale
26,931
10.72
US$288,814 		26,931 10.72 US$288,814
2025-05-23 2025-05-22
US AxoGen, Inc. (AXGN)
S Sale
7,212 -32.0%
11.20
US$80,774 		7,212 -32.0% 11.20 US$80,774
2025-05-23 2025-05-22
US AxoGen, Inc. (AXGN)
S Sale
12,850 -36.3%
11.20
US$143,920 		12,850 -36.3% 11.20 US$143,920
2025-05-22 2025-05-22
US AxoGen, Inc. (AXGN)
PrS Proposed sale
32,339
11.15
US$360,580 		32,339 11.15 US$360,580
2025-05-23 2025-05-19
US AxoGen, Inc. (AXGN)
S Sale
2,525 -10.1%
11.63
US$29,366 		2,525 -10.1% 11.63 US$29,366